Levodropropizine
Levodropropizine is a peripherally acting antitussive agent used in pharmaceutical research to study the inhibition of the cough reflex without central nervous system side effects.
Description
Zyntex supplies high-purity Levodropropizine (CAS 99291-25-1) tailored specifically for global pharmaceutical manufacturing plants, pulmonary research laboratories, and international organic synthesis loops.
Functioning as a highly specific afferent C-fiber inhibitor and sensory peptide modulation regulator, it delivers precise substance profiles that ensure uniform dry batch integration and highly predictable dissolution kinetics in liquefied carrier matrices. Furthermore, its strictly minimized chemical volatile impurities and high enantiomeric purity geometry make it an ideal selection for sensitive oral syrup compounding and non-sedative therapeutic fluid production. Accordingly, formulation scientists specify this active substance to stabilize modern bronchoprotective carriers and maintain exact potency integrity across continuous processing cycles.
Afferent C-Fiber Inhibition and Syrup Vehicle Stability
Excellent crystalline solubility performance and outstanding peripheral absorption profiles provide a distinct operational edge when engineering modern fast-acting cough management formulations. This active pharmaceutical solid operates by blocking the release of sensory neuropeptides like substance P within respiratory pathways to break down hyper-reactive bronchospasm setups, supplying the exact chemical mechanisms required to induce rapid antitussive clearance without altering raw liquid vehicle uniformity. It assists compounding engineers in maintaining strict active concentration uniformity across high-speed liquid blending and bottle filling lines, mitigating trace sedimentation risks within automated volumetric dosing machinery. For instance, specialized pharmaceutical facilities incorporate this refined levo-isomer powder as a core active component in targeted non-central nervous system syrup batches. As a consequence, it maximizes the technical throughput of automated packaging machinery and continuous quality assurance checks. Consequently, Zyntex coordinates clean room crystallization paths to eliminate downstream dextrorotatory structural shifts from your factory schedule.
In addition to this, Zyntex coordinates climate-controlled logistics for pilot-scale manufacturing operations and advanced pulmonary formulation research centers. The compound maintains its refined molecular integrity under strict storage parameters, preventing temperature-induced chemical breakdown or photolytic degradation during automated mechanical blending steps. It advances contemporary medical engineering by providing a thoroughly analyzed, highly predictable respiratory raw material that meets international USP/EP monograph standards. Simultaneously, it remains a critical chemical standard for routine high-performance liquid chromatography (HPLC) chiral calibration assays and spectrophotometric validation testing loops. In brief, our product functions as a dependable chemical foundation, supporting both the performance of commercial clinical batches and the analytical rigor of specialized industrial laboratories.
Primary Medical Sectors for Levodropropizine
This high-purity crystalline active drug compound delivers crucial technical value within these four primary industrial sectors:
🧴 Antitussive Syrups
Primary non-sedative hammadde source used for formulating high-stability pediatric and adult oral liquid cough mixtures. Hence, it directly supports optimal micro-dispersion control lines.
🧪 Oral Soluble Drops
Utilized as a high-purity active base to compound professional concentrated drop solutions requiring rapid peripheral airway response. Clearly, it is key for uniform dissolving patterns.
🔬 Chiral Bioassays
Acts as an essential reference active standard for monitoring optical rotation profiles, evaluating enantiomeric purity, and routine diagnostic controls. Resultantly, it guarantees excellent matrix clarity.
🏢 Pulmonary Studies
Used as a professional active component for validating advanced non-opioid airway model pathways and specialized liposomal aerosol delivery loops. Specifically, it confirms optimal reaction pathways.
Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Levodropropizine (S-Dropropizine) |
| Assay / Purity (HPLC) | 99.0% to 101.0% (Dry Basis) |
| Appearance | White or almost white crystalline powder |
| Melting Point | 60°C to 63°C |
| Enantiomeric Purity | Min 99.5% S-isomer (Chiral HPLC) |
| CAS Number | 99291-25-1 |
⚠️ Safety & Handling (RESPIRATORY ACTIVE API): Levodropropizine is an active peripheral antitussive therapeutic pharmaceutical compound. Direct inhalation of fine crystalline bulk powder dust, intensive transdermal interaction, or accidental ingestion poses moderate risk factors of localized respiratory tract irritation, occupational skin sensitization, and potential mild psychomotor deceleration if significant industrial exposure levels occur. Therefore, store strictly inside original heavy-duty airtight container units located within a cool, exceptionally dry, and properly ventilated pharmaceutical warehouse zone completely isolated from direct sunlight, moisture, and alkaline element fluxes. Keep compounding packaging hermetically sealed when not actively dispensing. Proper personal protective equipment (PPE)—including high-grade chemical-resistant nitrile manufacturing gloves, safety protective glasses with side frames, and a certified particulate filter dust mask—must be worn during all commercial batch scaling routines. Review the Safety Data Sheet (SDS).
